Evidence map›Paper›PMID 40385578›Full record

ArticleFrontiers in medicine2025

Metabolomic insights into amino acid signatures and pathways associated with osteoporosis in Iranian elderly population.

Hojat Dehghanbanadaki, Azin Soltani, Ziba Majidi, Mostafa Rezaei-Tavirani, Gita Shafiee, Afshin Ostovar, Fatemeh Bandarian, Niloufar Najjar, Bagher Larijani, Iraj Nabipour and 3 more

Abstract read
In one paragraph

Article in Frontiers in medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Hojat DehghanbanadakiMetabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Azin SoltaniSchool of Medicine, Tehran University of Medical Sciences (TUMS), Tehran, Iran.
Ziba MajidiDepartment of Medical Laboratory Science, School of Allied Medical Sciences, Tehran University of Medical Sciences, Tehran, Iran.
Mostafa Rezaei-TaviraniProteomics Research Center, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Gita ShafieeChronic Diseases Research Center, Endocrinology and Metabolism Population Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Afshin OstovarOsteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh BandarianMetabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Niloufar NajjarMetabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Bagher LarijaniEndocrinology and Metabolism Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Iraj NabipourThe Persian Gulf Marine Biotechnology Research Center, The Persian Gulf Biomedical Sciences Research Institute, Bushehr University of Medical Sciences, Bushehr, Iran.
Patricia KhashayarInternational Institute for Biosensing, University of Minnesota, Minneapolis, MN, United States.
Noushin FahimfarOsteoporosis Research Center, Endocrinology and Metabolism Clinical Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.
Farideh RaziMetabolomics and Genomics Research Center, Endocrinology and Metabolism Molecular-Cellular Sciences Institute, Tehran University of Medical Sciences, Tehran, Iran.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Osteoporosis poses a serious health risk to the elderly, particularly in developing countries like Iran. We aimed to determine the 20-amino acids-signatures and pathways associated with osteoporosis in the Iranian elderly population. Methods: We analyzed the data from the Bushehr Elderly Health Program (BEHP). In the BEHP cohort, participants aged 50 and older in Bushehr, Iran were selected using a multistage stratified random sampling approach. We used logistic regression, pathway enrichment, and pathway impact analysis to determine the metabolites and pathways altered in osteoporosis. AUC-ROC curve analysis assessed the clinical significance of metabolites in differentiating between osteoporosis and control groups. Results: This study included 1916 participants (1,097 women and 819 men). In women, glycine, citrulline, serine, and aspartic acid were associated with 27, 25, 23, and 21% higher risk of osteoporosis. In men, tyrosine, leucine, valine, and lysine were related with a 24, 22, 22, and 22% reduction in the risk of osteoporosis, respectively. The most impactful altered metabolite pathway among the osteoporotic individuals was "phenylalanine, tyrosine and tryptophan biosynthesis" in both genders. In women, citrulline had an AUC of 0.63 for distinguishing between individuals with osteoporosis and healthy controls. In men, valine, leucine, and tyrosine showed AUC values of 0.62, 0.61, and 0.61, respectively. Conclusion: Osteoporosis is associated with altered serum amino acids levels in both men and women. The condition is associated with several altered metabolic pathways, with "phenylalanine, tyrosine, and tryptophan biosynthesis" being the most important one. These metabolite signatures and pathways could be targeted for the prevention and management of osteoporosis in older adults.

Indexed as

amino acidBMDelderlymetabolic pathwaymetabolomicosteoporosis

Identifiers

PMID40385578
PMCPMC12081454

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.